ALKBH5 is an important component of the m6A modifying enzyme complex, and it has been reported that deletion of the m6A demethylase ALKBH5 can make patients more sensitive to cancer immunotherapy (Fang et al., 2020). The gene discussed is ALKBH5; the disease is cancer.